Literature DB >> 8449056

Deaths in bacteremic pneumococcal pneumonia. A comparison of two populations--Huntington, WVa, and Stockholm, Sweden.

A Ortqvist1, M Kalin, I Julander, M A Mufson.   

Abstract

The case fatality rate in bacteremic pneumococcal pneumonia (Pnb) has been reported to be lower in Sweden than in the United States. We retrospectively compared 231 adult Pnb patients in Stockholm (STO), Sweden, with 107 patients infected with the same serotypes or groups in Huntington, WVa (HWV). The total case fatality rate was 11/231 (5 percent) in STO versus 28/107 (26 percent) in HWV (p < 0.001), being significantly lower in STO for all age groups. Patients from HWV more often had preexisting chronic diseases, while alcoholism was more prevalent in STO. The case fatality rate was similar among alcoholics in STO and HWV, while it was much higher in nonalcoholic patients with chronic diseases in HWV (22/73;30 percent) than in STO (2/88;2 percent) (p < 0.001). No bias was found that could account for more than a small part of the higher case fatality rate in HWV. Thus, underlying chronic diseases in HWV accounted for some of the increased risk of death in this patient group. However, the major part of the difference in death rates between HWV and STO remains unexplained.

Entities:  

Mesh:

Year:  1993        PMID: 8449056     DOI: 10.1378/chest.103.3.710

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia.

Authors:  J A Brandenburg; T J Marrie; C M Coley; D E Singer; D S Obrosky; W N Kapoor; M J Fine
Journal:  J Gen Intern Med       Date:  2000-09       Impact factor: 5.128

2.  Levels of azithromycin and alpha-1 acid glycoprotein in serum in patients with community-acquired pneumonia.

Authors:  R Bohte; H Mattie; P J van den Broek
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

3.  The intensive care management, mortality and prognostic indicators in severe community-acquired pneumococcal pneumonia.

Authors:  P D Potgieter; J M Hammond
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

4.  Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia.

Authors:  R Bohte; J W van't Wout; S Lobatto; A Blussé van Oud Alblas; M Boekhout; E H Nauta; J Hermans; P J van den Broek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

5.  Bacteremia with Streptococcus pneumoniae: sepsis and other risk factors for 30-day mortality--a hospital-based cohort study.

Authors:  J S Christensen; T G Jensen; H J Kolmos; C Pedersen; A Lassen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-13       Impact factor: 3.267

6.  Structural insights into catalytic and substrate binding mechanisms of the strategic EndA nuclease from Streptococcus pneumoniae.

Authors:  Andrea F Moon; Marika Midon; Gregor Meiss; Alfred Pingoud; Robert E London; Lars C Pedersen
Journal:  Nucleic Acids Res       Date:  2010-11-26       Impact factor: 16.971

7.  Death or survival from invasive pneumococcal disease in Scotland: associations with serogroups and multilocus sequence types.

Authors:  Donald Inverarity; Karen Lamb; Mathew Diggle; Chris Robertson; David Greenhalgh; Tim J Mitchell; Andrew Smith; Johanna M C Jefferies; Stuart C Clarke; Jim McMenamin; Giles F S Edwards
Journal:  J Med Microbiol       Date:  2011-03-10       Impact factor: 2.472

Review 8.  Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae.

Authors:  Joseph F Plouffe; Daniel R Martin
Journal:  Infect Dis Clin North Am       Date:  2004-12       Impact factor: 5.982

9.  Occurrence of invasive pneumococcal disease and number of excess cases due to influenza.

Authors:  Katarzyna Grabowska; Liselotte Högberg; Pasi Penttinen; Ake Svensson; Karl Ekdahl
Journal:  BMC Infect Dis       Date:  2006-03-20       Impact factor: 3.090

Review 10.  Respiratory infections: community-acquired pneumonia and newer microbes.

Authors:  H Y Reynolds
Journal:  Lung       Date:  1996       Impact factor: 2.584

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.